You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

non-small cell lung carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stage IB Non-small Cell Lung Cancer

Completed
  • Stage IB Non-Small Cell Lung Carcinoma
    • Shanghai, China
      180 Fenglin Road
    Jul 29, 2023

    Immune Checkpoint Inhibitors in Non-Small Cell Lung Carcinoma

    Active, not recruiting
    • Non Small Cell Lung Cancer
    • Immune signature in serum associated to the metabolic signature
    • Meta-genomic signature of intestinal flora
    • La Tronche, Isère, France
      University Hospital, Grenoble
    Jan 6, 2023

    Dietary Practices and Locally Advanced Lung Cancer (LUNGDIET)

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Self-administered survey at hospital
    • +2 more
    • (no location specified)
    Oct 3, 2023

    Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage II, Nonsmall Cell Lung Cancer Stage III Trial in Tampa (Genomically

    Recruiting
    • Nonsmall Cell Lung Cancer
    • +3 more
    • Genomically Guided Radiation Therapy (RT)
    • Tampa, Florida
      Moffitt Cancer Center
    May 23, 2023

    Stage IA Non-Small Cell Lung Carcinoma, Stage IB Non-Small Cell Lung Carcinoma, Stage IIA Non-Small Cell Lung Carcinoma Trial in

    Active, not recruiting
    • Stage IA Non-Small Cell Lung Carcinoma
    • +3 more
    • Computed Tomography Perfusion Imaging
    • +2 more
    • Los Angeles, California
      USC / Norris Comprehensive Cancer Center
    Aug 5, 2022

    NSCLC Trial in Xinxiang (CCCR-NK92 cells)

    Enrolling by invitation
    • Non-small Cell Lung Cancer
    • CCCR-NK92 cells
    • Xinxiang, Henan, China
      The first Affiliated Hospital of Xinxiang Medical University
    Aug 31, 2022

    QOL After SURGERY and ADJUVANT Treatment

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Quality of Life
    • Questionnaires
    • Salamanca, Spain
      Hospital Clínico Universitario
    Oct 30, 2023

    Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Duarte, New Haven (procedure, drug, radiation, other)

    Not yet recruiting
    • Lung Non-Small Cell Carcinoma
    • Stage IV Lung Cancer AJCC v8
    • Biospecimen Collection
    • +5 more
    • Duarte, California
    • +1 more
    Aug 24, 2023

    Non-Squamous Non-Small Cell Lung Carcinoma, Stage I NSCLC, Stage IA Non-Small Cell Lung Carcinoma Trial in Abington,

    Active, not recruiting
    • Non-Squamous Non-Small Cell Lung Carcinoma
    • +7 more
    • Nivolumab
    • +3 more
    • Abington, Pennsylvania
    • +1 more
    Sep 14, 2022

    Non-small Cell Lung Carcinoma Trial (Pembrolizumab, Paclitaxel, Carboplatin)

    Completed
    Has Results
    • Non-small Cell Lung Carcinoma
    • Pembrolizumab
    • +7 more
    • (no location specified)
    Oct 13, 2022

    Observing Palliative Asymptomatic Centrally Located Advanced

    Active, not recruiting
    • Non-small Cell Lung Carcinoma
    • None: Questionnaire Study
    • Toronto, Ontario, Canada
      University Health Network, Princess Margaret Hospital
    Oct 6, 2022

    EGFR-Mutated Non-Small-Cell Lung Carcinoma, Small Cell/Neuroendocrine Trial run by the National Cancer Institute (NCI)

    Recruiting
    • EGFR-Mutated Non-Small-Cell Lung Carcinoma
    • Small Cell/Neuroendocrine
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Non-Small-Cell Lung Carcinoma, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma Trial (Liquid biopsy)

    Not yet recruiting
    • Non-Small-Cell Lung Carcinoma
    • +2 more
    • Liquid biopsy
    • (no location specified)
    Jan 24, 2023

    Non-small Cell Lung Carcinoma Trial (BPI-361175)

    Not yet recruiting
    • Non-small Cell Lung Carcinoma
    • (no location specified)
    Oct 18, 2022

    Metastatic NSCLC (NSCLC), NSCLC Metastatic, NSCLC Stage II Trial in Oldenburg (data collection)

    Recruiting
    • Metastatic Non-small Cell Lung Cancer (NSCLC)
    • +5 more
    • data collection
    • Oldenburg, Germany
      Pius-Hospital
    Jul 20, 2022

    Metastatic Squamous Non-Small Cell Lung Carcinoma Trial in Chicago (Cabozantinib 40 MG, Pembrolizumab 200mg)

    Recruiting
    • Metastatic Squamous Non-Small Cell Lung Carcinoma
    • Cabozantinib 40 MG
    • Pembrolizumab 200mg
    • Chicago, Illinois
      University of Illinois at Chicago
    Jan 20, 2023

    Tabrecta® (Capmatinib) in South Korea

    Not yet recruiting
    • Non-Small-Cell Lung Carcinoma
    • Capmatinib
    • (no location specified)
    Jan 19, 2023

    NSCLC, Non-Small Cell Lung Carcinoma, NSCLC Trial run by the National Cancer Institute (NCI) (biological, drug, device)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • +3 more
    • Montanide (Registered Trademark) ISA-51 VG Adjuvant
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Lung Cancer Trial (ortataxel)

    Completed
    • Lung Cancer
    • (no location specified)
    Sep 23, 2022

    Stage I NSCLC AJCC v7, Stage IA Non-Small Cell Lung Carcinoma AJCC v7, Stage IB Non-Small Cell Lung Carcinoma AJCC v7 Trial in

    Recruiting
    • Stage I Non-Small Cell Lung Cancer AJCC v7
    • +6 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    May 2, 2022

    Non-small-cell Lung Carcinoma Trial in Beijing (SY-3505)

    Recruiting
    • Non-small-cell Lung Carcinoma
    • Beijing, China
      Cancer Hospital, Chinese Academy of Medical Sciences
    May 11, 2023

    Lung Cancer Circulating Tumor Cells

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • Sample
    • Nice, France
      CHU de Nice
    Dec 5, 2022

    NSCLC Trial in Melbourne, London (Pembrolizumab, Radiotherapy (SABR))

    Completed
    • Non-small Cell Lung Cancer
    • Melbourne, Victoria, Australia
    • +1 more
    May 23, 2022

    EGFRmutant Stage IIIB/C or IV Non-squamous NSCLC Trial in Worldwide (Atezolizumab, Bevacizumab, Carboplatin)

    Active, not recruiting
    • EGFRmutant Stage IIIB/C or IV Non-squamous NSCLC
    • Großhansdorf, Germany
    • +17 more
    Jan 12, 2023

    Nonsmall Cell Lung Cancer Stage III, Unresectable Non-Small Cell Lung Carcinoma Trial in Winston-Salem (drug, other, diagnostic

    Not yet recruiting
    • Nonsmall Cell Lung Cancer Stage III
    • Unresectable Non-Small Cell Lung Carcinoma
    • Winston-Salem, North Carolina
      Wake Forest Baptist Comprehensive Cancer Center
    Jan 12, 2023